SCHEMBL19743761

SCHEMBL19743761

O=C(NCC1CCCCC1)c1cc(=O)c2ccccc2o1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METTL3 Q86U44 3/20 0.65
LMNA P02545 1/20 0.64
MAOB P27338 3/20 0.58
ACHE P22303 3/20 0.58
BCHE P06276 1/20 0.58
SMN1; SMN2 Q16637 2/20 0.54
METTL14 Q9HCE5 1/20 0.54
HTT P42858 1/20 0.54
KDM4E B2RXH2 1/20 0.52
USP2 O75604 1/20 0.52
CSNK2A2 P19784 1/20 0.52
PTGS1 P23219 1/20 0.52
CSNK2B P67870 1/20 0.52
CSNK2A1 P68400 1/20 0.52
CSNK2A3 Q8NEV1 1/20 0.52
MAOA P21397 1/20 0.52
RECQL P46063 1/20 0.52
POLB P06746 1/20 0.52
PKM P14618 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29986215 1.00 METTL3 (0.65) METTL3LMNAMAOBACHEBCHE
SCHEMBL21174951 0.99 LMNA (0.66) METTL3LMNAMAOBACHEBCHE
SCHEMBL28997464 0.89 ACHE (0.72) METTL3LMNAMAOBACHEBCHE
SCHEMBL21175008 0.89 LMNA (0.63) METTL3LMNAMAOBACHEBCHE
SCHEMBL21174996 0.88 LMNA (0.62) METTL3LMNAMAOBACHEBCHE
SCHEMBL21174991 0.88 ACHE (0.74) METTL3LMNAMAOBACHEBCHE
SCHEMBL21174960 0.87 LMNA (0.60) METTL3LMNAMAOBACHEBCHE
SCHEMBL29985626 0.85 AKR1B1 (0.54) METTL3MAOBACHEMAOAPOLB
SCHEMBL19744394 0.85 AKR1B1 (0.54) METTL3MAOBACHEMAOAPOLB
SCHEMBL19744231 0.85 MAOB (0.57) METTL3MAOBACHEBCHEMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109641864-B Anti-infective agents 邓迪大学 2023-04-04 CN disclosed
US-11485720-B2 Anti-infective agents UNIVERSITY OF DUNDEE (GB) 2022-11-01 US disclosed
US-20210101877-A1 ANTI-INFECTIVE AGENTS UNIVERSITY OF DUNDEE (GB) 2021-04-08 US disclosed
US-20190225592-A1 ANTI-INFECTIVE AGENTS UNIVERSITY OF DUNDEE (GB) 2019-07-25 US disclosed
EP-3472141-A1 ANTI-INFECTIVE AGENTS University Of Dundee (GB) 2019-04-24 EP disclosed
CN-109641864-A ANTI-INFECTIVE AGENTS 邓迪大学 2019-04-16 CN disclosed
WO-2017221002-A1 ANTI-INFECTIVE AGENTS UNIVERSITY OF DUNDEE (GB) 2017-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11485720-B2 Anti-infective agents C1R, RRS1, ARG1 METTL3 4284/4885LMNA 2536/4885MAOB 2696/4885
US-20210101877-A1 ANTI-INFECTIVE AGENTS C1R, RRS1, ARG1 METTL3 4284/4885LMNA 2536/4885MAOB 2696/4885
US-20190225592-A1 ANTI-INFECTIVE AGENTS C1R, ARG1, MSR1 METTL3 4440/4885LMNA 2610/4885MAOB 2283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.